Primary Job Title Director Primary Organization 
Blockade Medical
Location Irvine, California, United States Regions Greater Los Angeles Area, West Coast, Western US Gender Male Also Known As David
Website www.balt-corp.com LinkedIn View on LinkedIn
Dave is Chief Technology Officer of Balt and a seasoned medical device executive with 20 years of experience working within the medical device and interventional neurovascular industry.
Prior to Balt's acquisition of Blockade Medical in 2016, he was a co-founding member of Blockade Medical, he also served as VP Product
Development/Clinical Research & General Manager of MindFrame Inc.(acquired by Covidien in 2012), a developer, manufacturer and marketer of minimally invasive products for the treatment of acute ischemic stroke based in Irvine, CA.
Prior to that he served as Director of Clinical Research/R&D for Microvention (acquired by Terumo in 2006), a developer, manufacturer and marketer of minimally invasive products for treatment of cerebral and vascular peripheral diseases based in Aliso Viejo, CA.
His past roles have included Director of Technology Development of Micrus Endovascular (IPO in 2004 and acquired by J&J/Codman in 2010), Sr. R&D/Pilot Engineer of Boston Scientific in Watertown, MA, and R&D Process Engineer at IMPRA, Inc. in Tempe, AZ (acquired by C.R. Bard in 1996). Dave received a B.S. in Plastics Engineering from University of Lowell, in Lowell, Massachusetts. He holds several US and international patents for medical devices.
